BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10752873)

  • 1. The effect of etidronate on late development of heterotopic ossification after spinal cord injury.
    Banovac K
    J Spinal Cord Med; 2000; 23(1):40-4. PubMed ID: 10752873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of heterotopic ossification after spinal cord injury.
    Banovac K; Gonzalez F; Renfree KJ
    J Spinal Cord Med; 1997 Jan; 20(1):60-5. PubMed ID: 9097258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and management of heterotopic ossification in patients with spinal cord injury.
    Banovac K; Gonzalez F
    Spinal Cord; 1997 Mar; 35(3):158-62. PubMed ID: 9076866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification.
    Banovac K; Gonzalez F; Wade N; Bowker JJ
    Paraplegia; 1993 Oct; 31(10):660-6. PubMed ID: 8259329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphosphonate treatment for heterotopic ossification in spinal cord injury patients.
    Garland DE; Alday B; Venos KG; Vogt JC
    Clin Orthop Relat Res; 1983 Jun; (176):197-200. PubMed ID: 6406123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury.
    Estrores IM; Harrington A; Banovac K
    J Spinal Cord Med; 2004; 27(5):434-7. PubMed ID: 15648796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for treating acute heterotopic ossification.
    Haran M; Bhuta T; Lee B
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003321. PubMed ID: 15495048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of the three-phase bone scan in the early diagnosis of heterotopic ossification (HO) and in the evaluation of Didronel therapy.
    Freed JH; Hahn H; Menter R; Dillon T
    Paraplegia; 1982 Aug; 20(4):208-16. PubMed ID: 6215609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WITHDRAWN: Pharmacological interventions for treating acute heterotopic ossification.
    Haran MJ; Bhuta T; Lee BS
    Cochrane Database Syst Rev; 2010 May; 2010(5):CD003321. PubMed ID: 20464723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of serum creatine kinase in early diagnosis of heterotopic ossification.
    Sherman AL; Williams J; Patrick L; Banovac K
    J Spinal Cord Med; 2003; 26(3):227-30. PubMed ID: 14997963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of heterotopic ossification after spinal cord injury with COX-2 selective inhibitor (rofecoxib).
    Banovac K; Williams JM; Patrick LD; Levi A
    Spinal Cord; 2004 Dec; 42(12):707-10. PubMed ID: 15179440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of heterotopic ossification after spinal cord injury.
    Banovac K; Sherman AL; Estores IM; Banovac F
    J Spinal Cord Med; 2004; 27(4):376-82. PubMed ID: 15484668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury.
    Ploumis A; Donovan JM; Olurinde MO; Clark DM; Wu JC; Sohn DJ; O'Connor KC
    J Spinal Cord Med; 2015 Mar; 38(2):193-8. PubMed ID: 24820653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP.
    Finerman GA; Stover SL
    Metab Bone Dis Relat Res; 1981; 3(4-5):337-42. PubMed ID: 6820114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterotopic ossification mimicking infection in patients with traumatic spinal cord injury.
    Citak M; Grasmücke D; Salber J; Cruciger O; Meindl R; Schildhauer TA; Aach M
    Technol Health Care; 2016; 24(1):87-91. PubMed ID: 26409557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide assessment of heterotopic ossification in spinal cord injury patients.
    Prakash V
    J Am Paraplegia Soc; 1983 Jan; 6(1):10-2. PubMed ID: 6310049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterotopic bone formation: clinical, laboratory, and imaging correlation.
    Orzel JA; Rudd TG
    J Nucl Med; 1985 Feb; 26(2):125-32. PubMed ID: 3918147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory heterotopic ossification with complications.
    Yin KS; James J; Lew K; Little JW
    J Spinal Cord Med; 2001; 24(2):119-22. PubMed ID: 11587419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoarthrosis in heterotopic ossification in spinal cord-injured patients.
    Subbarao JV
    Am J Phys Med Rehabil; 1990 Apr; 69(2):88-90. PubMed ID: 2109987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection of heterotopic ossification and Didronel therapy--regaining wheelchair independence in the spinal cord injured patient.
    Subbarao JV; Nemchausky BA; Gratzer M
    J Am Paraplegia Soc; 1987; 10(1):3-7. PubMed ID: 3106569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.